# Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19

> **NCT04377997** · PHASE2 · UNKNOWN · sponsor: **Massachusetts General Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Cardiovascular Diseases
- COVID-19

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT04377997
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-15
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04377997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04377997, "Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04377997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*